Clio infotech Limited has received regulatory approval to relocate its registered office from Maharashtra to Gujarat, marking a significant corporate restructuring move. The company announced this development on March 12, 2026, following receipt of the approval order from regulatory authorities.

Regulatory Approval Details

The Regional Director (Western Region), Ministry of Corporate Affairs issued the approval order on March 10, 2026, which was received by the company on March 12, 2026. This approval encompasses both the shifting of the registered office and the consequent alteration of the company's Memorandum of Association.

Office Relocation Specifics

The company will transition from its current registered office in Mumbai, Maharashtra to a new location in Ahmedabad, Gujarat. The current registered office is situated at Room No 3 & 5 Sheth Lalji Dayalji Building, Dadi Sheth, Agiary Lane, Malharao Wadi, Kalbadevi, Mumbai, Maharashtra, 400002.

Compliance and Documentation

Clio Infotech Limited will complete the relocation process by filing the necessary e-forms on the Ministry of Corporate Affairs portal. This administrative step is essential to formalize the registered office change and ensure compliance with regulatory requirements. The company had previously communicated about this planned relocation in an earlier correspondence dated October 28, 2025.

Company Information

The announcement was made under the company's BSE script code 530839 and company symbol CLIOINFO. The disclosure was signed by Ms. Nikita Tiwadi, Managing Director, with DIN 10646772, ensuring proper corporate governance protocols were followed in the announcement process.

Clio Infotech Limited announced significant board changes following its meeting held on February 24, 2026, involving the appointment of a new director and acceptance of a resignation that led to comprehensive committee restructuring. The company filed detailed regulatory disclosures under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Composition Changes

The company's Board of Directors approved two major personnel decisions during their meeting held at the registered office from 1:30 PM to 2:00 PM. The board appointed Mr. Ashwini Kumar Pareek (DIN: 11551819) as Additional Director (Non-Executive) and Chairman of the company, while simultaneously accepting the resignation of Mr. Sujal Amrutbhai Koshti (DIN: 10649068) as Non-Executive Non-Independent Director.

New Director Profile

Mr. Ashwini Kumar Pareek brings multidisciplinary expertise spanning Research & Business Analytics, SOP Development, Project Management, Data Analysis, Creative Media Production, and Generative AI Solutions. According to the company's regulatory filing, he is described as a dynamic and results-driven professional with a strong foundation in analytical thinking and structured execution, combining strategic insight, technical depth, and creative capability to drive organizational growth and operational excellence. The company has confirmed that Mr. Pareek is not debarred from holding the office of director by virtue of any SEBI order or other authority.

Committee Reconstitution

The board changes necessitated reconstitution of all board committees effective February 24, 2026. Mr. Pareek replaced Mr. Koshti across all committee memberships while maintaining the same chairperson structure across all committees.

Updated Committee Structure

Regulatory Compliance and Documentation

The company filed comprehensive disclosures including detailed annexures covering the new director's profile, resignation details, and committee restructuring information. Mr. Koshti's resignation letter, dated February 24, 2026, confirmed that there were no material reasons for his resignation beyond pre-occupations and personal reasons. He also stepped down from his membership in the Audit Committee, Nomination and Remuneration Committee, and Stakeholder Relationship Committee.

The regulatory filing was signed by Managing Director Nikita Tiwadi (DIN: 10646772) and submitted to BSE Limited under the company's scrip code 530839. The changes ensure continuity in board operations while bringing fresh expertise through the new appointment, maintaining compliance with corporate governance requirements throughout the transition.